Pfizer (LIM:PFE) Construction In Progress: $0 Mil (As of Mar. 2026)


LIM:PFE Pfizer Inc LIM:PFE
59 GF Score
Price $23.80
GF Value $26.20
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Construction In Progress?

Pfizer LIM:PFE -0.83% 59 Construction In Progress is $0 Mil as of Mar. 2026. GuruFocus rates LIM:PFE with a GF Score™ of 59/100 and a GF Value™ of $26.20 (Fairly Valued). The stock has 5 warning signs investors should review.

Pfizer's quarterly construction in progress increased from Sep. 2025 ($0 Mil) to Dec. 2025 ($4,805 Mil) but then declined from Dec. 2025 ($4,805 Mil) to Mar. 2026 ($0 Mil).

Pfizer's annual construction in progress declined from Dec. 2023 ($5,925 Mil) to Dec. 2024 ($4,937 Mil) and declined from Dec. 2024 ($4,937 Mil) to Dec. 2025 ($4,805 Mil).

Pfizer Construction In Progress Historical Data

* Premium members only.

The historical data trend for Pfizer's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Construction In Progress Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,822.00 4,875.00 5,925.00 4,937.00 4,805.00

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 4,805.00 0.00
LIM:PFE
59GF Score
Pfizer Inc LIM:PFE
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0 Mil mean?
Pfizer (LIM:PFE) has a Construction In Progress of $0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Pfizer and its competitors.
Is Pfizer's Construction In Progress too high?
Pfizer's current Construction In Progress is $0 Mil. Overall, Pfizer has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Construction In Progress compare to GILD and BMY?
Pfizer's Construction In Progress of $0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Pfizer and its competitors. Pfizer's current Construction In Progress is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (LIM:PFE) is currently considered Fairly Valued. The stock's GF Value™ is $26.20, compared to a current price of $23.80 — trading 9.2% below its estimated fair value. The current Construction In Progress is $0 Mil. Pfizer's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Pfizer (LIM:PFE), the current Construction In Progress is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (LIM:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of $23.80 is trading 9.2% below its estimated GF Value™ of $26.20. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for LIM:PFE:

  • Construction In Progress: $0 Mil
  • GF Value™: $26.20 vs. price of $23.80 (9.2% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the LIM:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
59GF Score

Get the complete analysis for LIM:PFE

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$23.80
Price
$26.20
GF Value